{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T08:21:19Z","timestamp":1778228479722,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T00:00:00Z","timestamp":1482278400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00296-016-3634-9","type":"journal-article","created":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T09:22:01Z","timestamp":1482312121000},"page":"313-322","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Longitudinal transition trajectory of gouty arthritis and its comorbidities: a population-based study"],"prefix":"10.1007","volume":"37","author":[{"given":"Chien-Fang","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-Chi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Chuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao-Yuan","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-I","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Chia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,21]]},"reference":[{"key":"3634_CR1","first-page":"301","volume":"20","author":"SY Chuang","year":"2011","unstructured":"Chuang SY, Lee SC, Hsieh YT, Pan WH (2011) Trends in hyperuricemia and gout prevalence: Nutrition and Health Survey in Taiwan from 1993\u20131996 to 2005\u20132008. Asia Pac J Clin Nutr 20:301\u2013308","journal-title":"Asia Pac J Clin Nutr"},{"key":"3634_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1185\/03007995.2015.1087979","volume":"31","author":"RJ Johnson","year":"2015","unstructured":"Johnson RJ (2015) Why focus on uric acid? Curr Med Res Opin 31:3\u20137","journal-title":"Curr Med Res Opin"},{"key":"3634_CR3","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","volume":"63","author":"Y Zhu","year":"2011","unstructured":"Zhu Y, Pandya BJ, Choi HK (2011) Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007\u20132008. Arthritis Rheum 63:3136\u20133141","journal-title":"Arthritis Rheum"},{"key":"3634_CR4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/acr.20344","volume":"63","author":"PC Grayson","year":"2011","unstructured":"Grayson PC, Kim SY, LaValley M, Choi HK (2011) Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res 63:102\u2013110","journal-title":"Arthritis Care Res"},{"key":"3634_CR5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/acr.20065","volume":"62","author":"SY Kim","year":"2010","unstructured":"Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA (2010) Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res 62:170\u2013180","journal-title":"Arthritis Care Res"},{"issue":"Suppl 2","key":"3634_CR6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1185\/03007995.2015.1087981","volume":"31","author":"G Mancia","year":"2015","unstructured":"Mancia G, Grassi G, Borghi C (2015) Hyperuricemia, urate deposition and the association with hypertension. Curr Med Res Opin 31(Suppl 2):15\u201319","journal-title":"Curr Med Res Opin"},{"key":"3634_CR7","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1185\/03007995.2010.533647","volume":"26","author":"RA Brook","year":"2010","unstructured":"Brook RA, Forsythe A, Smeeding JE, Lawrence Edwards N (2010) Chronic gout: epidemiology, disease progression, treatment and disease burden. Curr Med Res Opin 26:2813\u20132821","journal-title":"Curr Med Res Opin"},{"key":"3634_CR8","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/rheumatology\/kes253","volume":"52","author":"PC Robinson","year":"2012","unstructured":"Robinson PC, Merriman TR, Herbison P, Highton J (2012) Hospital admissions associated with gout and their comorbidities in New Zealand and England 1999\u20132009. Rheumatology 52:118\u2013126","journal-title":"Rheumatology"},{"key":"3634_CR9","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/ard.2007.081604","volume":"67","author":"JA Singh","year":"2008","unstructured":"Singh JA, Strand V (2008) Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis 67:1310\u20131316","journal-title":"Ann Rheum Dis"},{"key":"3634_CR10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/annrheumdis-2013-203779","volume":"74","author":"P Richette","year":"2013","unstructured":"Richette P, Clerson P, Perissin L, Flipo RM, Bardin T (2013) Revisiting comorbidities in gout: a cluster analysis. Ann Rheum Dis 74:142\u2013147","journal-title":"Ann Rheum Dis"},{"key":"3634_CR11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1471-2458-7-220","volume":"7","author":"B Hildrum","year":"2007","unstructured":"Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA (2007) Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health 7:220","journal-title":"BMC Public Health"},{"key":"3634_CR12","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/01.CIR.99.9.1165","volume":"99","author":"P Jousilahti","year":"1999","unstructured":"Jousilahti P, Vartiainen E, Tuomilehto J, Puska P (1999) Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation 99:1165\u20131172","journal-title":"Circulation"},{"issue":"5 Suppl 51","key":"3634_CR13","first-page":"S115","volume":"26","author":"SY Kim","year":"2008","unstructured":"Kim SY, De Vera MA, Choi HK (2008) Gout and mortality. Clin Exp Rheumatol 26(5 Suppl 51):S115\u2013S119","journal-title":"Clin Exp Rheumatol"},{"key":"3634_CR14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/0003-4819-157-4-201208210-00003","volume":"157","author":"E Krishnan","year":"2012","unstructured":"Krishnan E, Lingala B, Bhalla V (2012) Low-level lead exposure and the prevalence of gout: an observational study. Ann Intern Med 157:233\u2013241","journal-title":"Ann Intern Med"},{"key":"3634_CR15","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s00296-015-3284-3","volume":"35","author":"N Rashid","year":"2015","unstructured":"Rashid N, Levy GD, Wu YL, Zheng C, Koblick R, Cheetham TC (2015) Patient and clinical characteristics associated with gout flares in an integrated healthcare system. Rheumatol Int 35:1799\u20131807","journal-title":"Rheumatol Int"},{"key":"3634_CR16","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/acr.20479","volume":"63","author":"MA DeMarco","year":"2011","unstructured":"DeMarco MA, Maynard JW, Huizinga MM, Baer AN, Kottgen A, Gelber AC et al (2011) Obesity and younger age at gout onset in a community-based cohort. Arthritis Care Res 63:1108\u20131114","journal-title":"Arthritis Care Res"},{"key":"3634_CR17","first-page":"39","volume":"125","author":"S Kumar","year":"2012","unstructured":"Kumar S, Gupta R, Suppiah R (2012) Gout in women: differences in risk factors in young and older women. NZ Med J 125:39\u201345","journal-title":"NZ Med J"},{"key":"3634_CR18","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/rheumatology\/ket293","volume":"52","author":"OO Seminog","year":"2013","unstructured":"Seminog OO, Goldacre MJ (2013) Gout as a risk factor for myocardial infarction and stroke in England: evidence from record linkage studies. Rheumatology 52:2251\u20132259","journal-title":"Rheumatology"},{"key":"3634_CR19","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/jamainternmed.2015.3540","volume":"175","author":"AW Hsing","year":"2015","unstructured":"Hsing AW, Ioannidis JP (2015) Nationwide population science: lessons from the Taiwan National Health Insurance Research Database. JAMA Intern Med 175:1527\u20131529","journal-title":"JAMA Intern Med"},{"key":"3634_CR20","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/2012.jama.11975","volume":"308","author":"CY Wu","year":"2012","unstructured":"Wu CY, Chen YJ, Ho HJ, Hsu YC, Kuo KN, Wu MS et al (2012) Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection. JAMA 308:1906\u20131914","journal-title":"JAMA"},{"key":"3634_CR21","first-page":"925","volume":"59","author":"MD Harris","year":"1999","unstructured":"Harris MD, Siegel LB, Alloway JA (1999) Gout and hyperuricemia. Am Fam Phys 59:925\u2013934","journal-title":"Am Fam Phys"},{"key":"3634_CR22","volume-title":"Latent class and latent transition analysis with applications in the social, behavioral, and health sciences","author":"LM Collins","year":"2010","unstructured":"Collins LM, Lanza S (2010) Latent class and latent transition analysis with applications in the social, behavioral, and health sciences. Wiley, Hoboken"},{"key":"3634_CR23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1017\/S0033291715002196","volume":"46","author":"S Landau","year":"2016","unstructured":"Landau S, Harris V, Burn DJ, Hindle JV, Hurt CS, Samuel M et al (2016) Anxiety and anxious-depression in Parkinson\u2019s disease over a 4-year period: a latent transition analysis. Psychol Med 46:657\u2013667","journal-title":"Psychol Med"},{"key":"3634_CR24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2188\/jea.JE20120201","volume":"23","author":"N Soto-Ramirez","year":"2013","unstructured":"Soto-Ramirez N, Ziyab AH, Karmaus W, Zhang H, Kurukulaaratchy RJ, Ewart S et al (2013) Epidemiologic methods of assessing asthma and wheezing episodes in longitudinal studies: measures of change and stability. J Epidemiol 23:399\u2013410","journal-title":"J Epidemiol"},{"key":"3634_CR25","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2105\/AJPH.2013.301642","volume":"104","author":"C Mathur","year":"2014","unstructured":"Mathur C, Stigler MH, Erickson DJ, Perry CL, Forster JL (2014) Transitions in smoking behavior during emerging adulthood: a longitudinal analysis of the effect of home smoking bans. Am J Public Health 104:715\u2013720","journal-title":"Am J Public Health"},{"key":"3634_CR26","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/S0735-1097(01)01643-6","volume":"38","author":"AJ Maxwell","year":"2001","unstructured":"Maxwell AJ, Bruinsma KA (2001) Uric acid is closely linked to vascular nitric oxide activity. Evidence for mechanism of association with cardiovascular disease. J Am Coll Cardiol 38:1850\u20131858","journal-title":"J Am Coll Cardiol"},{"key":"3634_CR27","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.semnephrol.2011.08.007","volume":"31","author":"W Doehner","year":"2011","unstructured":"Doehner W, Landmesser U (2011) Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options. Semin Nephrol 31:433\u2013440","journal-title":"Semin Nephrol"},{"issue":"Supplementum 3","key":"3634_CR28","doi-asserted-by":"crossref","first-page":"S309","DOI":"10.33549\/physiolres.933442","volume":"65","author":"A Puzserova","year":"2016","unstructured":"Puzserova A, Bernatova I (2016) Blood pressure regulation in stress: focus on nitric oxide-dependent mechanisms. Physiol Res 65(Supplementum 3):S309\u2013S342","journal-title":"Physiol Res"},{"key":"3634_CR29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/(SICI)1099-0895(1998090)14:3<241::AID-DMR216>3.0.CO;2-R","volume":"14","author":"ML Honing","year":"1998","unstructured":"Honing ML, Morrison PJ, Banga JD, Stroes ES, Rabelink TJ (1998) Nitric oxide availability in diabetes mellitus. Diabetes Metab Rev 14:241\u2013249","journal-title":"Diabetes Metab Rev"},{"key":"3634_CR30","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1172\/JCI4829","volume":"103","author":"O Feron","year":"1999","unstructured":"Feron O, Dessy C, Moniotte S, Desager JP, Balligand JL (1999) Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest 103:897\u2013905","journal-title":"J Clin Invest"},{"key":"3634_CR31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/B978-0-12-800254-4.00016-7","volume":"96","author":"P Kruzliak","year":"2014","unstructured":"Kruzliak P, Maruyama J, Maruyama K (2014) Role of nitric oxide in pathophysiology and treatment of pulmonary hypertension. Vitam Horm 96:407\u2013424","journal-title":"Vitam Horm"},{"issue":"Suppl 2","key":"3634_CR32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1185\/03007995.2015.1087980","volume":"31","author":"F Perez-Ruiz","year":"2015","unstructured":"Perez-Ruiz F, Becker MA (2015) Inflammation: a possible mechanism for a causative role of hyperuricemia\/gout in cardiovascular disease. Curr Med Res Opin 31(Suppl 2):9\u201314","journal-title":"Curr Med Res Opin"},{"key":"3634_CR33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/03009742.2013.878387","volume":"43","author":"CJ Chen","year":"2014","unstructured":"Chen CJ, Yen JH, Chang SJ (2014) Gout patients have an increased risk of developing most cancers, especially urological cancers. Scand J Rheumatol 43:385\u2013390","journal-title":"Scand J Rheumatol"},{"key":"3634_CR34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jbspin.2011.09.011","volume":"79","author":"CF Kuo","year":"2012","unstructured":"Kuo CF, Luo SF, See LC, Chou IJ, Fang YF, Yu KH (2012) Increased risk of cancer among gout patients: a nationwide population study. Joint Bone Spine 79:375\u2013378","journal-title":"Joint Bone Spine"},{"key":"3634_CR35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2001-1326-1-16","volume":"1","author":"MA Fini","year":"2012","unstructured":"Fini MA, Elias A, Johnson RJ, Wright RM (2012) Contribution of uric acid to cancer risk, recurrence, and mortality. Clin Trans Med 1:16","journal-title":"Clin Trans Med"},{"key":"3634_CR36","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.7150\/ijbs.7.1003","volume":"7","author":"S Braun","year":"2011","unstructured":"Braun S, Bitton-Worms K, LeRoith D (2011) The link between the metabolic syndrome and cancer. Int J Biol Sci 7:1003\u20131015","journal-title":"Int J Biol Sci"},{"key":"3634_CR37","doi-asserted-by":"crossref","first-page":"19880","DOI":"10.18632\/oncotarget.4166","volume":"6","author":"J You","year":"2015","unstructured":"You J, Liu WY, Zhu GQ, Wang OC, Ma RM, Huang GQ et al (2015) Metabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer. Oncotarget 6:19880\u201319890","journal-title":"Oncotarget"},{"key":"3634_CR38","doi-asserted-by":"crossref","first-page":"e5194","DOI":"10.1371\/journal.pone.0005194","volume":"4","author":"JM Orengo","year":"2009","unstructured":"Orengo JM, Leliwa-Sytek A, Evans JE, Evans B, van de Hoef D, Nyako M et al (2009) Uric acid is a mediator of the Plasmodium falciparum-induced inflammatory response. PLoS One 4:e5194","journal-title":"PLoS One"},{"key":"3634_CR39","first-page":"157","volume":"104","author":"CC Lin","year":"2005","unstructured":"Lin CC, Lai MS, Syu CY, Chang SC, Tseng FY (2005) Accuracy of diabetes diagnosis in health insurance claims data in Taiwan. JFMA 104:157\u2013163","journal-title":"JFMA"},{"key":"3634_CR40","first-page":"254","volume":"114","author":"CY Hsieh","year":"2015","unstructured":"Hsieh CY, Chen CH, Li CY, Lai ML (2015) Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database. JFMA 114:254\u2013259","journal-title":"JFMA"},{"key":"3634_CR41","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2188\/jea.JE20140076","volume":"24","author":"CL Cheng","year":"2014","unstructured":"Cheng CL, Lee CH, Chen PS, Li YH, Lin SJ, Yang YH (2014) Validation of acute myocardial infarction cases in the national health insurance research database in Taiwan. J Epidemiol 24:500\u2013507","journal-title":"J Epidemiol"},{"key":"3634_CR42","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2147\/CEOR.S93323","volume":"8","author":"YN Hung","year":"2016","unstructured":"Hung YN, Kadziola Z, Brnabic AJ, Yeh JF, Fuh JL, Hwang JP et al (2016) The epidemiology and burden of Alzheimer\u2019s disease in Taiwan utilizing data from the National Health Insurance Research Database. Clinicoecon Outcomes Res 8:387\u2013395","journal-title":"Clinicoecon Outcomes Res"},{"key":"3634_CR43","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/HYPERTENSIONAHA.114.05105","volume":"66","author":"CC Hsu","year":"2015","unstructured":"Hsu CC, Wang H, Hsu YH, Chuang SY, Huang YW, Chang YK et al (2015) Use of nonsteroidal anti-inflammatory drugs and risk of chronic kidney disease in subjects with hypertension: nationwide longitudinal cohort study. Hypertension 66:524\u2013533","journal-title":"Hypertension"},{"key":"3634_CR44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11926-015-0495-2","volume":"17","author":"AM Abeles","year":"2015","unstructured":"Abeles AM (2015) Hyperuricemia, gout, and cardiovascular disease: an update. Curr Rheumatol Rep 17:13","journal-title":"Curr Rheumatol Rep"},{"key":"3634_CR45","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3899\/jrheum.121231","volume":"41","author":"R Akkineni","year":"2014","unstructured":"Akkineni R, Tapp S, Tosteson AN, Lee A, Miller KL, Choi HK et al (2014) Treatment of asymptomatic hyperuricemia and prevention of vascular disease: a decision analytic approach. J Rheumatol 41:739\u2013748","journal-title":"J Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3634-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-016-3634-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3634-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T10:08:20Z","timestamp":1718964500000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-016-3634-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,21]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["3634"],"URL":"https:\/\/doi.org\/10.1007\/s00296-016-3634-9","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,21]]}}}